Wall Street’s most bullish Uxin Limited (NASDAQ:UXIN) analysts are predicting the share price to blow past $14 per share during the next 12 months. The current median share price forecast by them is $9.3, suggesting that the stock could increase 150.67% in that time frame. The average price target of $10.1 calls for a nearly 172.24% increase in the stock price.

Uxin Limited (UXIN) trading activity significantly weakened as the volume at ready counter decreased to 6,154,460 shares versus 7,573,905 in average daily trading volume over the past 20 days. So far this year, the volume has averaged about 7,168,025 shares. The share price dropped -1.07% in recent trade and currently has a stock-market value of $1.11B. The shares finished at $3.71, after trading as low as $3.61 earlier in the session. It hit an intraday high Friday at $3.84. The stock is now 32.03% above against its bear-market low of $2.81 on December 04, 2018. It has retreated -182.75% since it’s 52-week high of $10.49 reached in June. Now the market price is down 0% on the year and down -23.66% YTD.

UXIN’s 50 day simple moving average (SMA 50) price is $5.38 and its stock currently has a total float of 25M shares. Its weekly volatility is hovering around 12.36% and felt 21.09% volatility in price over a month. On the upside, the share price will test short term resistance at around $3.83. On a downside, the stock is likely to find some support, which begins at $3.6. The failure to get near-term support could push it to $3.49.

It had seen a positive analyst call from JP Morgan, which upgraded the stock from Neutral to Overweight on January 10. Analysts at Goldman, shed their positive views on December 21 by lowering it fromBuy to Neutral. Analysts at Goldman, made their first call about the stock on August 16, recommending it is Buy.

Also, it is trading at rather expensive levels at just over 2.83x price/book and 2.62x price/sales. UXIN’s ROE is 113.3%, which is also considerably better than the industry’s ROE of 22.19%. It’s also very liquid in the near term, with a current ratio of 1.7. The stock has a debt/capital of 0.93.

Revenue for the recent quarter stood at $124.45 million, down -54209% on last year and above the $121.91 million predicted by analysts. For this quarter, Wall Street analysts forecast revenue in a range of $707.17 million to $797.72 million, which should be compared with $0 generated last year.